Medications for Lymphangioleiomyomatosis
3 results
Sirolimus (sirolimus)
(Sirolimus)Camber Pharmaceuticals, Inc.
Usage: Sirolimus oral solution is indicated for the prophylaxis of organ rejection in renal transplant patients aged 13 and older and for the treatment of lymphangioleiomyomatosis (LAM). It is used in conjunction with cyclosporine and corticosteroids, particularly in patients with varying immunologic risks.
Sirolimus (sirolimus)
(Sirolimus)Ascend Laboratories, LLC
Usage: Sirolimus is indicated for the prophylaxis of organ rejection in renal transplant patients aged 13 and older, particularly in high-risk groups, and for the treatment of lymphangioleiomyomatosis (LAM). Its use involves specific combinations with cyclosporine and corticosteroids based on immunologic risk levels.
Sirolimus (sirolimus)
(sirolimus)NorthStar RxLLC
Usage: Sirolimus tablets are indicated for the prophylaxis of organ rejection in renal transplant patients aged 13 and older and for treating lymphangioleiomyomatosis (LAM). In renal transplantation, dosing varies based on immunologic risk, with specific recommendations for combining with cyclosporine and corticosteroids.